Success Story Clinical Testing & Intelligence

Driving innovation in neurology tech

Client

Leading neurology tech brand

Program & Deliverables

PR & Awareness, Content Marketing, Creative & Branding, Demand & Lead Generation

Introduction

Elevating market leadership positioning

PAN recently designed an integrated communications and target marketing campaign to elevate a global leader in ultra-sensitive biomarker detection and secure its market leadership position in neurology tech through the launch of its subsidiary, further spotlighting its blood testing assay following the US FDA approval of a major Alzheimer’s Disease treatment.

SOLUTION

Connecting the dots from brand to demand

PAN’s integrated strategy targeted lab developers, scientists and the neuro-research community to ride the wave of neurological advancement signaled by the FDA approval as it impacts the future of treatment for dementia, Alzheimer’s disease and ALS. The campaign anchored into earned media, organic and paid social media to drive lead-generation, third-party influencer engagement, and paid search strategy.

Result

Generating excitement around blood-based diagnostic testing

PAN’s efforts to help the brand capitalize on this milestone neurological breakthrough has thus far generated 8 press interviews with top-tier publications (AP, Reuters, STAT News), 3 feature articles, and notable social shares/impressions as the excitement around blood-based diagnostic testing continues to rise.

We are proud to partner with such innovative brands in the life sciences, pushing the boundaries of medical marvels and broadening our understanding of—and creating groundbreaking treatments for—the chronic conditions of our time.

Matthew Briggs, Senior Vice President, Healthcare at PAN
Matthew Briggs, Senior Vice President, Healthcare at PAN Communications, headshot

More work

See more

good stuff

View Our Full Portfolio Let’s Talk

Inserting executives into the national conversation on price transparency 

Clinical Testing & Intelligence